Palvella Therapeutics (PVLA) Prepaid Assets (2013 - 2026)
Palvella Therapeutics' (PVLA) quarterly Prepaid Assets came in at $1.4 million in Q1 2026, down 24.9% year-on-year from $1.8 million in Q1 2025, and up 37.11% on a QoQ basis from $1.0 million in Q4 2025.
Palvella Therapeutics (PVLA) Prepaid Assets (2013 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 14 years of Prepaid Assets data on file, last reported at $1.4 million in Q1 2026.
- On a quarterly basis, Prepaid Assets fell 24.9% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 24.9% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, down 56.23% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.4 million, up from $1.0 million in the prior quarter.
- Over the last five years, Prepaid Assets for PVLA reached as high as $11.1 million in Q1 2023 and fell as low as $198000.0 in Q4 2023.
- Historically, Prepaid Assets has averaged $4.3 million across 5 years, with a median of $2.3 million in 2024.
- On a YoY basis, Prepaid Assets climbed as much as 1059.6% in 2024 and fell as far as 96.94% in 2024.
- Year by year, Prepaid Assets stood at $3.2 million in 2022, then slumped by 93.84% to $198000.0 in 2023, then jumped by 1059.6% to $2.3 million in 2024, then plunged by 56.23% to $1.0 million in 2025, then surged by 37.11% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $1.4 million in Q1 2026, $1.0 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Palvella Therapeutics | 1.84 Bn | 1.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 280,000.00 |
| Jun 30, 2024 | 649,000.00 |
| Mar 31, 2024 | 2.97 Mn |
| Dec 31, 2023 | 198,000.00 |
| Sep 30, 2023 | 9.15 Mn |
| Jun 30, 2023 | 10.65 Mn |
| Mar 31, 2023 | 11.07 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Sep 30, 2022 | 7.91 Mn |
| Jun 30, 2022 | 8.70 Mn |
| Mar 31, 2022 | 9.84 Mn |
| Dec 31, 2021 | 6.55 Mn |
| Sep 30, 2021 | 5.95 Mn |
| Jun 30, 2021 | 5.77 Mn |